Sanara MedTech to Be Acquired by MiMedx in $35/Share Cash-and-Stock Deal
SMTI sits 89% above its 52-week low of $16.047 on elevated volume (4.5× avg).
Summary
Sanara MedTech will be acquired by MiMedx Group for $33.00 cash and 0.4735 MiMedx shares per Sanara share, a total value of $35 per share. The deal creates a leading regenerative medicine company and is expected to close by end of 2026.
Key Events · M&A and Partnerships · SMTI
-
Definitive Merger Agreement Signed
Sanara has entered into a definitive agreement to be acquired by MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock per Sanara share, implying a total value of $35 per share based on MiMedx's 5-day average price of $4.22.
-
Transaction Value and Premium
The deal values Sanara at an enterprise value of approximately $350 million and represents a 46% premium to Sanara's 30-day volume-weighted average price as of July 28, 2026.
-
Shareholder Lock-Up Secured
Stockholders holding approximately 38.9% of Sanara's voting power have entered into voting agreements to support the merger, significantly de-risking the shareholder approval process.
-
Strategic Rationale and Synergies
The combination is expected to nearly double MiMedx's surgical revenue, create a combined company with over $400 million in 2027 revenue and 20%+ adjusted EBITDA margins, and generate over $20 million in run-rate cost synergies.
Analysis · SMTI · Industrial Applications And Services
In a deal that reshapes its standalone future, Sanara MedTech has agreed to be acquired by MiMedx Group through a cash-and-stock transaction valuing Sanara at $35 per share—a 46% premium to its 30-day VWAP. The merger unites two regenerative medicine companies, nearly doubling MiMedx's surgical revenue and creating a platform with expected 2027 revenue exceeding $400 million. Under the terms, Sanara shareholders will receive $33.00 in cash and 0.4735 MiMedx shares per Sanara share, with the stock component valued at $2.00 based on MiMedx's recent average price. Both boards have unanimously approved the transaction, which is expected to close by year-end, pending Sanara shareholder approval and regulatory clearances.
At the time of this filing, SMTI was trading at $30.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $277.2M. The 52-week trading range was $16.05 to $35.95. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.